← Open Payments lookup

NPI 1013410380: Open Payments

NPI 1013410380. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$151 in 8 payments from 6 companies in 2025. Trend: 2023 $275 · 2024 $136 · 2025 $151

Food & beverage: $151
CompanyPaymentsAmount
ABBVIE INC.3$69
GlaxoSmithKline, LLC.1$22
AstraZeneca Pharmaceuticals LP1$17
Novo Nordisk Inc1$15
PFIZER INC.1$14
Bayer Healthcare Pharmaceuticals Inc.1$14

Products named: VRAYLAR, UBRELVY, TRELEGY ELLIPTA, AIRSUPRA, Wegovy, PREVNAR 20, Kerendia.